Women over 55 account for the majority of breast cancer diagnoses, but age is only one piece of the picture. About 1 in 8 women (13%) will develop breast cancer in their lifetime, and that baseline risk shifts dramatically depending on genetics, body composition, hormonal history, and daily habits. Here’s what actually moves the needle.
Age Is the Single Biggest Factor
Breast cancer is overwhelmingly a disease of older women. According to SEER data from the National Cancer Institute, nearly 47% of new cases occur in women 65 and older, and another 25% in women between 55 and 64. Only about 2% of cases are diagnosed in women under 35. The risk climbs steadily with each decade of life, which is the main reason screening recommendations start at age 40.
Genetics and Family History
Inherited changes in the BRCA1 or BRCA2 genes create the sharpest jump in risk. More than 60% of women who carry one of these mutations will develop breast cancer during their lifetime, compared to 13% of women overall. That’s roughly a fivefold increase over the general population. These mutations also tend to cause cancer at younger ages and in more aggressive forms.
You don’t need a known gene mutation for family history to matter. Having one first-degree relative (mother, sister, or daughter) diagnosed with breast cancer doubles your risk. If two first-degree relatives have been diagnosed, your risk is about five times higher than average. This elevated risk likely reflects a combination of shared genes, some of which haven’t been identified yet, along with shared environmental exposures.
Breast Density
Women with extremely dense breast tissue have roughly 2.4 times the cancer risk of women with mostly fatty breasts, based on large population screening studies. Earlier research suggested the gap could be as high as four to six times, though newer data has settled on a more modest but still meaningful increase. Dense tissue also makes tumors harder to spot on a standard mammogram, which can delay detection. If your mammogram report mentions dense breasts (categories C or D on the BI-RADS scale), this is worth discussing with your doctor in the context of your other risk factors.
Hormonal Exposure Over a Lifetime
The longer your body is exposed to estrogen, the higher your breast cancer risk. This is why two reproductive milestones matter: when your periods started and when they stopped. Women who got their first period before age 12 have a 23% higher risk compared to those who started at 15 or later. Late menopause extends estrogen exposure on the other end.
Combination hormone therapy (estrogen plus progestin) taken for menopausal symptoms also raises risk. The landmark Women’s Health Initiative trial found a 24% increase in breast cancer risk over an average of 5.6 years of use. For women who started therapy close to menopause, risk climbed by about 50% within just the first two years. The good news: after stopping, the elevated risk appears to fade within two to three years.
Body Weight After Menopause
Before menopause, the ovaries produce most of the body’s estrogen. After menopause, that job shifts to fat tissue. This is why carrying excess body fat after menopause is a meaningful risk factor: more fat tissue produces more estrogen, which fuels the growth of hormone-sensitive breast tumors. The relationship is direct: higher BMI correlates with higher circulating estrogen and higher breast cancer risk. Regular physical activity helps lower estrogen levels in the blood, which is one reason exercise is consistently linked to lower breast cancer risk in postmenopausal women.
Alcohol Consumption
Alcohol raises breast cancer risk at even modest levels. Women who have less than one drink per day still face a 5% increase compared to non-drinkers. The risk scales up from there: one to two drinks daily is associated with a 30 to 50% increase. Each additional 10 grams of alcohol per day (roughly three-quarters of a standard drink) adds about 7% to the overall risk. Unlike many risk factors, this one is entirely modifiable.
Race and Ethnicity
White women have a slightly higher overall incidence rate (137.9 per 100,000) than Black women (131.3 per 100,000). But Black women are 38% more likely to die from the disease. Five-year survival rates tell a stark story: 84% for Black women compared to 93% for White women. This gap reflects a combination of factors, including higher rates of aggressive tumor subtypes, later-stage diagnoses, and longstanding disparities in access to quality care. Among women under 40, Black women actually have higher incidence rates than White women.
Chest Radiation at a Young Age
Women who received radiation therapy to the chest before age 30, often as treatment for childhood cancers like Hodgkin lymphoma, face a dramatically elevated risk. Studies of childhood cancer survivors found that mantle field radiation (targeted to the chest and neck area) was associated with a breast cancer incidence more than 24 times that of the general population. Even lower-dose whole-lung radiation carried a risk more than 43 times higher. Guidelines recommend these women begin annual screening with both mammography and breast MRI starting at age 25 or eight years after radiation, whichever comes later.
How These Risks Stack Up
No single factor works in isolation. A 65-year-old woman with dense breasts, a family history, and daily alcohol use faces a very different risk profile than a 65-year-old with none of those factors. Risk assessment tools used in clinical settings combine multiple variables to estimate your individual probability rather than relying on any one category.
The factors you can’t change (age, genetics, family history, race, and reproductive timing) set your baseline. The factors you can change (alcohol intake, body weight, physical activity, and decisions about hormone therapy) shift that baseline up or down. For average-risk women, the USPSTF recommends mammography every two years starting at age 40. The American Cancer Society recommends annual screening from 45 to 54, with the option to start at 40. Women at higher risk due to genetics or prior chest radiation follow a different, more intensive screening schedule.